Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice

Cellular Physiology and Biochemistry

Volumn 26, Issue 4-5, 2010, Pages 749-760

  Dhami, Rajwinder ^a   He, Xingxuan ^a   Schuchman, Edward H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cell growth; Fibrosis; Signal transduction; Sphingolipids

Indexed keywords

ACID CERAMIDASE; ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; COLLAGEN; SMALL INTERFERING RNA; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; IN VITRO STUDY; KNOCKOUT MOUSE; LUNG FIBROSIS; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE;

MUS;

EID: 78149436318     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322342     Document Type: Article

References (44)

1. Maher TM, Wells AU, Laurent GJ: Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J 2007;30:835-839.
2. Hauber HP, Blaukovitsch M: Current and future treatment options in idiopathic pulmonary fibrosis. Inflamm Allergy Drug Targets 2010; in press.
3. Chua F, Gauldie J, Laurent GL: Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol 2005;33:9-13.
4. Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao A, Polosukhin V, Wain J, Karimi-Shah B, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD: The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 2008;14:45-54.
5. Scotton CJ, Chambers RC: Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007;132:1311-1321.
6. Phan SH: Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc 2008;5:335-337.
7. Smith EL, Schuchman EH: The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J 2008;22:3419-3431.
8. Jenkins RW, Canals D, Hannun YA: Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 2009;21:836-846.
9. Grassme H, Riethmuller J, Gulbins E: Biological aspects of ceramide enriched membrane domains. Prog Lipid Res 2007;46:161-170.
10. Hannun YA, Obeid, LM: Principles of bioactive lipid signaling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008;9:139-150.
11. He X, Okino N, Dhami R, Dagan A, Gatt S, Schulze H, Sandhoff K, Schuchman EH: Purification and characterization of recombinant, human acid ceramidase. Catalytic reactions and interactions with acid sphingomyelinase. J Biol Chem 2003;278:32978-32986.
12. Fyrst H, Saba JD: An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 2010;6:489-497.
13. Teichgraber V, Ulrich M, Endlich N, Riethmuller J, Wilker B, De Oliveria-Munding CC, van Heeckeren AM, Barr ML, von Kurthy G, Schmid KW, Weller M, Tummier B, Lang F, Grassme H, Doring G, Gulbins E: Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008;14:382-391.
14. Becker KA, Riethmuller J, Luth A, Doring G, Kleuser B, Gulbins E: Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Respir Cell Mol Biol 2010;42:716-724.
15. Riethmuller J, Anthonysamy J, Serra E, Schwab M, Doring G, Gulbins E: Therapeutic efficacy and safety of amitriptyline in patients with cystic fibrosis. Cell Physiol Biochem 2009;24:65-72.
16. Moles A, Tarrats N, Morales A, Dominguez M, Bataller R, Caballeria J, Garcia-Ruiz C, Fernandez-Checa JC, Mari M: Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrosis. Am J Path 2010;177:1214-1224.
17. Horinouchi K, Erlich S, Perl DP, Ferlinz K, Bisgaier CL, Sandhoff K, Desnick RJ, Stewart CL, Schuchman EH: Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet 1995;10:288-293.
18. Dhami R, He X, Gordon RE, Schuchman EH: Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. Lab Invest 2001;81:987-999.
19. Cooper JA, White D, Matthay R: Drug-induced pulmonary disease. Am Rev Respir Dis 1986;133:321-340.
20. Sigounas G, Salleng KJ, Mehlhop PD, Sigounas DG: Erythropoiten ameliorates chemotherapy-induced fibrosis of the lungs in a preclinical murine model. Int J Cancer 2008;122:2851-2857.
21. Moore BB, Hogaboam CM: Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;294:L152-60.
22. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M: The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40:362-382.
23. He X, Chen F, Dagan A, Gatt S, Schuchman EH: A fluorescence-based, high-performance liquid chromatographic assay to determine acid sphingomyelinase activity and diagnose types A and B Niemann-Pick disease. Anal Biochem 2003;314:116-120.
24. He X, Li CM, Park JH, Dagan A, Gatt S, Schuchman EH: A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity. Anal Biochem 1999;274:264-269.
25. Schneider EG, Kennedy EP: Phosphorylation of ceramide by diglyceride kinase preparations from Escherichia coli. J Biol Chem 1973;248:3739-3741.
26. He X, Huang CL, Schuchman EH: Quantitative analysis of sphingosine-1-phosphate by HPLC after naphthalene-2,3dicarboxaldehyde (NDA) derivatization. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:983-990.
27. Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R: Time course of bleomycin-induced lung fibrosis. Int J Exp Path 2002;83:111-119.
28. Barbas-Filho J V, Ferreira MA, Sesso A, Kairalla RA, Carvalho CR, Capelozzi VL: Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia (UIP). J Clin Pathol 2001;54:132-138.
29. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB: Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol Cell Physiol 1999;277:C1-C19.
30. Kanko Y, Hara N: Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol 1997;17:272-278.
31. Hagimoto N, Kuwano K, Miyazaki H, Kunitake R, Fujita M, Kawasaki M, Wang Q, Wang Y, Hyde DM, Gotwals PJ, Lobb RR, Ryan ST, Giri SN: Effect of antibody against integrin alpha4 on bleomycin-induced pulmonary fibrosis in mice. Biochem Pharmacol 2000;60:1949-1958.
32. Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, Hara N: Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2001;280:L316-L325.
33. Kuwano K: Involvement of epithelial cell apoptosis in interstitial lung diseases. Inter Med 2008;47:345-353.
34. Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, Crimi N, Sortino MA, Nicoletti F, Copani A, Vancheri C: TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res 2008;57:274-282.
35. Bouros D, Antoniou KM: Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur Respir J 2005;26;693-702.
36. Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T, Maeyama T, Hara N: Protection from lethal apoptosis in lipopolysaccharide- induced acute lung injury in mice by a caspase inhibitor. Am J Pathol 2000;157:597-603.
37. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM: Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005;11:491-498.
38. Shea BS, Brooks SF, Fontaine FA, Chun J, Luster AD, Tager AM: Prolonged S1P1 agonist exposure exacerbates vascular leak, fibrosis, and mortality after lung injury. Am J Respir Cell Mol Biol 2010; in press.
39. Kono Y, Nishiuma T, Nishimura Y, Kotani Y, Okada T, Nakamura S, Yokoyama M: Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Am J Respir Cell Mol Biol 2007;37:395-404.
40. Keller CD, Rivera Gil P, Tolle M, van der Giet M, Chun J, Radeke HH, Schafr-Korting M, Kleuser B: Immunomodulator FTY720 induces myofibroblast differentiation via lysophospholipid receptor S1P3 and Smad3 signaling. Am J Path 2007;170:281-292.
41. Mercier JC, Dinh-Xuan AT: Neutralizing ceramide: a major breakthrough or yet another marginal target for the treatment of acute lung injury? Pediatr Res 2005;57:319-321.
42. Von Bismarck P, Garcia Wistadt CF, Klemm K, Winoto-Morbach S, Uhlig U, Schutze S, Adam D, Lachmann B, Uhlig S, Krause MF: Improved pulmonary function by acid sphingomyelinase inhibition in a newborn piglet lavage model. Am J Respir Crit Care Med 2008;177:1233-1241.
43. Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ: Medical treatment of advanced tes-ticular cancer. JAMA 2008;299:672-684.
44. Martin W G, Ristow KM, Habermann TM, Colgan JP, Witzig TE, Ansell SM: Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma. J Clin Oncol 2005;23:7614-7620.